These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30288220)

  • 1. Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D
    Cao Y; Sun N; Zhang J; Liu Z; Tang YZ; Wu Z; Kim KM; Cheon SH
    Medchemcomm; 2018 Sep; 9(9):1457-1465. PubMed ID: 30288220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor.
    Adhikari P; Xie B; Semeano A; Bonifazi A; Battiti FO; Newman AH; Yano H; Shi L
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33924613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands.
    Cao Y; Min C; Acharya S; Kim KM; Cheon SH
    Bioorg Med Chem; 2016 Jan; 24(2):191-200. PubMed ID: 26707842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of bitopic ligands based on fallypride and evaluation of their affinity and selectivity towards dopamine D
    Tian GL; Hsieh CJ; Taylor M; Lee JY; Riad AA; Luedtke RR; Mach RH
    Eur J Med Chem; 2023 Dec; 261():115751. PubMed ID: 37688938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands.
    Cao Y; Paudel S; Zhang X; Kim KM; Cheon SH
    Bioorg Med Chem; 2015 Sep; 23(17):5264-72. PubMed ID: 26278029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Governing Selectivity of Dopamine Receptor Binding Compounds for D2R and D3R Subtypes.
    Hayatshahi HS; Luedtke RR; Taylor M; Chen PJ; Blass BE; Liu J
    J Chem Inf Model; 2021 Jun; 61(6):2829-2843. PubMed ID: 33988991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D
    Bonifazi A; Newman AH; Keck TM; Gervasoni S; Vistoli G; Del Bello F; Giorgioni G; Pavletić P; Quaglia W; Piergentili A
    ACS Chem Neurosci; 2021 Oct; 12(19):3638-3649. PubMed ID: 34529404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the dopamine D3 receptor: an overview of drug design strategies.
    Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V
    Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D
    Battiti FO; Cemaj SL; Guerrero AM; Shaik AB; Lam J; Rais R; Slusher BS; Deschamps JR; Imler GH; Newman AH; Bonifazi A
    J Med Chem; 2019 Jul; 62(13):6287-6314. PubMed ID: 31257877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands.
    Tan L; Zhou Q; Yan W; Sun J; Kozikowski AP; Zhao S; Huang XP; Cheng J
    J Med Chem; 2020 May; 63(9):4579-4602. PubMed ID: 32282200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants of selectivity and efficacy at the dopamine D3 receptor.
    Newman AH; Beuming T; Banala AK; Donthamsetti P; Pongetti K; LaBounty A; Levy B; Cao J; Michino M; Luedtke RR; Javitch JA; Shi L
    J Med Chem; 2012 Aug; 55(15):6689-99. PubMed ID: 22632094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D
    Shaik AB; Boateng CA; Battiti FO; Bonifazi A; Cao J; Chen L; Chitsazi R; Ravi S; Lee KH; Shi L; Newman AH
    J Med Chem; 2021 Oct; 64(20):15313-15333. PubMed ID: 34636551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D
    Reilly SW; Riad AA; Hsieh CJ; Sahlholm K; Jacome DA; Griffin S; Taylor M; Weng CC; Xu K; Kirschner N; Luedtke RR; Parry C; Malhotra S; Karanicolas J; Mach RH
    J Med Chem; 2019 May; 62(10):5132-5147. PubMed ID: 31021617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.
    Ananthan S; Saini SK; Zhou G; Hobrath JV; Padmalayam I; Zhai L; Bostwick JR; Antonio T; Reith ME; McDowell S; Cho E; McAleer L; Taylor M; Luedtke RR
    J Med Chem; 2014 Aug; 57(16):7042-60. PubMed ID: 25126833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkers in Bitopic Agonists Shape Bias Profile among Transducers for the Dopamine D2 and D3 Receptors.
    Semeano A; Garland R; Bonifazi A; Lee KH; Famiglietti J; Zhang W; Jo YJ; Battiti FO; Shi L; Newman AH; Yano H
    ACS Pharmacol Transl Sci; 2024 Aug; 7(8):2333-2349. PubMed ID: 39144557
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lee JY; Kim HY; Martorano P; Riad A; Taylor M; Luedtke RR; Mach RH
    Front Neurosci; 2024; 18():1380009. PubMed ID: 38655111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiral Cyclic Aliphatic Linkers as Building Blocks for Selective Dopamine D
    Battiti FO; Zaidi SA; Katritch V; Newman AH; Bonifazi A
    J Med Chem; 2021 Nov; 64(21):16088-16105. PubMed ID: 34699207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D
    Gogarnoiu ES; Vogt CD; Sanchez J; Bonifazi A; Saab E; Shaik AB; Soler-Cedeño O; Bi GH; Klein B; Xi ZX; Lane JR; Newman AH
    J Med Chem; 2023 Feb; 66(3):1809-1834. PubMed ID: 36661568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity.
    Banala AK; Levy BA; Khatri SS; Furman CA; Roof RA; Mishra Y; Griffin SA; Sibley DR; Luedtke RR; Newman AH
    J Med Chem; 2011 May; 54(10):3581-94. PubMed ID: 21495689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors.
    Michino M; Donthamsetti P; Beuming T; Banala A; Duan L; Roux T; Han Y; Trinquet E; Newman AH; Javitch JA; Shi L
    Mol Pharmacol; 2013 Dec; 84(6):854-64. PubMed ID: 24061855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.